Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Second Opinion® BLE

K-Number: K243230 · 2025-05-09

ApplicantPearl, Inc.
Decision Date2025-05-09
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Second Opinion® BLE is the device name listed in this FDA 510(k) record. The listed applicant is Pearl, Inc.. It received FDA 510(k) clearance on 2025-05-09 under 510(k) number K243230. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Second Opinion® BLE?

Second Opinion® BLE is a medical device that received FDA 510(k) clearance on 2025-05-09. The listed applicant is Pearl, Inc.. The 510(k) number is K243230.

When did Second Opinion® BLE receive FDA 510(k) clearance?

Second Opinion® BLE received FDA 510(k) clearance on 2025-05-09, under 510(k) number K243230.

Who is the listed applicant for Second Opinion® BLE?

The FDA 510(k) record lists Pearl, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Second Opinion® BLE?

The FDA product code for Second Opinion® BLE is QIH.

Other records listing Pearl, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 8 devices →

Related Devices (Code: QIH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.